IO Biotech Management
Management criteria checks 0/4
IO Biotech's CEO is MBZ Zocca, appointed in Jan 2015, has a tenure of 9.33 years. total yearly compensation is $1.65M, comprised of 32.9% salary and 67.1% bonuses, including company stock and options. directly owns 0.097% of the company’s shares, worth $93.40K. The average tenure of the management team and the board of directors is 1.1 years and 3 years respectively.
Key information
MBZ Zocca
Chief executive officer
US$1.6m
Total compensation
| CEO salary percentage | 32.9% |
| CEO tenure | 9.3yrs |
| CEO ownership | 0.1% |
| Management average tenure | 1.1yrs |
| Board average tenure | 3yrs |
Recent management updates
Recent updates
We Think IO Biotech (NASDAQ:IOBT) Needs To Drive Business Growth Carefully
Feb 10
We Think IO Biotech (NASDAQ:IOBT) Needs To Drive Business Growth Carefully
Jun 15We Think IO Biotech (NASDAQ:IOBT) Needs To Drive Business Growth Carefully
Jan 20IO Biotech names new CFO
Oct 13We're Keeping An Eye On IO Biotech's (NASDAQ:IOBT) Cash Burn Rate
Sep 27IO Biotech GAAP EPS of -$0.64
Aug 11We're Keeping An Eye On IO Biotech's (NASDAQ:IOBT) Cash Burn Rate
Jun 14We Think IO Biotech (NASDAQ:IOBT) Needs To Drive Business Growth Carefully
Feb 25CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$2m | US$541k | -US$86m |
| Sep 30 2023 | n/a | n/a | -US$80m |
| Jun 30 2023 | n/a | n/a | -US$74m |
| Mar 31 2023 | n/a | n/a | -US$71m |
| Dec 31 2022 | US$734k | US$515k | -US$71m |
| Sep 30 2022 | n/a | n/a | -US$74m |
| Jun 30 2022 | n/a | n/a | -US$65m |
| Mar 31 2022 | n/a | n/a | -US$87m |
| Dec 31 2021 | US$8m | US$399k | -US$75m |
| Sep 30 2021 | n/a | n/a | -US$56m |
| Jun 30 2021 | n/a | n/a | -US$54m |
| Mar 31 2021 | n/a | n/a | -US$17m |
| Dec 31 2020 | US$409k | US$307k | -US$15m |
Compensation vs Market: MBZ's total compensation ($USD1.65M) is above average for companies of similar size in the US market ($USD667.63K).
Compensation vs Earnings: MBZ's compensation has increased whilst the company is unprofitable.
CEO
MBZ Zocca (55 yo)
9.3yrs
Tenure
US$1,645,088
Compensation
Dr. Mai-Britt Zocca, Ph D, also known as MBZ, was also the Founder and Chief Executive Officer of Onconox ApS since July 2011 until May 2019. She serves as Director at Valo Therapeutics Ltd since June 2020...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 9.3yrs | US$1.65m | 0.097% $ 93.4k | |
| Secretary | 1.3yrs | US$917.30k | 0.0075% $ 7.2k | |
| Chief Medical Officer | less than a year | US$920.76k | no data | |
| Founder & Clinical Advisor | no data | no data | no data | |
| Founder & Scientific Advisor | no data | no data | no data | |
| Founder | no data | no data | no data | |
| Founder | no data | no data | no data | |
| Chief Financial Officer | 1.6yrs | US$904.15k | 0.11% $ 108.6k | |
| Chief Technical Officer | less than a year | no data | no data | |
| Senior Vice President of Regulatory Affairs | 2.3yrs | no data | no data | |
| Chief Business Officer | less than a year | no data | no data | |
| Senior VP of Commercial Development & Portfolio Lead | less than a year | no data | no data |
1.1yrs
Average Tenure
53.5yo
Average Age
Experienced Management: IOBT's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 2.6yrs | US$1.65m | 0.097% $ 93.4k | |
| Founder & Clinical Advisor | no data | no data | no data | |
| Founder & Scientific Advisor | no data | no data | no data | |
| Independent Director | 2.3yrs | US$124.17k | 0% $ 0 | |
| Independent Director | 8.4yrs | US$114.14k | 0% $ 0 | |
| Independent Director | 6yrs | US$133.00k | 0% $ 0 | |
| Independent Director | 3.3yrs | US$112.75k | 0% $ 0 | |
| Sr. Clinical Advisor & Member of the Scientific Advisory Board | no data | no data | no data | |
| Strategic Advisory Board Member | no data | no data | no data | |
| Independent Chairman | 7.7yrs | US$145.75k | 0% $ 0 | |
| Independent Director | less than a year | US$52.48k | no data | |
| Independent Director | less than a year | US$112.61k | no data |
3.0yrs
Average Tenure
63yo
Average Age
Experienced Board: IOBT's board of directors are not considered experienced ( 3 years average tenure), which suggests a new board.